Cytomegalovirus IL-10 in Plasma as a Marker of Active Infection in Allogeneic Hematopoietic Transplant Recipients: An Exploratory Study.

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41527921

Ángela Sánchez-Simarro; Ariadna Pérez; Carlos Solano; David Navarro; Eliseo Albert; Estela Gimenez; Ester Colomer; Jose Luis Piñana

Jan 13, 2026